Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials
Year: 2010
Type: article
Abstract: Among the key challenges in Alzheimer's disease drug development is the timely completion of clinical trials. Unfortunately, clinical trials often suffer from slow or insufficient enrollment. Successful clinical trial recruitment describes a balance between expeditiously achieving full enrollment and ensuring an appropriate study sample. Investigators face a number of challenges to the successful negotiation of this balance. The failure to address these challenges means that drug development may take more time and money and that trial results may not adequately represent drug efficacy or may not be applicable beyond the study. We review the challenges to recruitment and retention in Alzheimer's disease clinical trials and present a framework to address them.
Source: Alzheimer s Research & Therapy
DOI: 10.1186/alzrt58
Authors: Joshua D Grill, Jason Karlawish
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,290
Funder: National Institute on Aging
OpenAlex ID: W2157764095
